Teva MDL Loss Shows DPAs Can Return To Haunt Civil Suits
In ongoing multidistrict antitrust litigation alleging price-fixing by numerous generic-drug manufacturers, the U.S. District Court for the Eastern District of Pennsylvania issued a significant opinion on July 27 with direct implications...To view the full article, register now.
Already a subscriber? Click here to view full article